mouse fcγriv cells Search Results


anti mouse cd16 2  (Bio X Cell)
93
Bio X Cell anti mouse cd16 2
Anti Mouse Cd16 2, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti mouse cd16 2/product/Bio X Cell
Average 93 stars, based on 1 article reviews
anti mouse cd16 2 - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier
adcc effector cells jurkat cell line expressing the mouse fcγriv cell-surface receptor  (Promega)
90
Promega adcc effector cells jurkat cell line expressing the mouse fcγriv cell-surface receptor
Adcc Effector Cells Jurkat Cell Line Expressing The Mouse Fcγriv Cell Surface Receptor, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/adcc effector cells jurkat cell line expressing the mouse fcγriv cell-surface receptor/product/Promega
Average 90 stars, based on 1 article reviews
adcc effector cells jurkat cell line expressing the mouse fcγriv cell-surface receptor - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
mfcγriv effector cells  (Promega)
90
Promega mfcγriv effector cells
Mfcγriv Effector Cells, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mfcγriv effector cells/product/Promega
Average 90 stars, based on 1 article reviews
mfcγriv effector cells - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
genetically modified jurkat cells expressing the mouse fcγriv with a luciferase reporter gene  (Promega)
90
Promega genetically modified jurkat cells expressing the mouse fcγriv with a luciferase reporter gene
Whole inactivated virus (WIV) with beta-propiolactone (BPL) and inactivated split vaccine combining BPL inactivation and Triton X-100 splitting were compared for two different vaccinations with WT viruses or mHA viruses. Vaccines were tested without adjuvant or with the addition of CpG 1018 (30 µg) as explained in Fig. . A Heatmap of IgG binding serum antibodies against a panel of recombinant influenza B HA proteins. B Heatmap of hemagglutination inhibition (HI) titer against a panel of influenza B viruses. C Heatmap of ADCC activity against three influenza B viruses. To perform the ADCC reporter assay, MDCK cells were infected with each virus at an MOI of 5 (single-cycle replication). One day after infection, mouse sera were added to the cells and incubated for 30 min <t>and</t> <t>genetically</t> modified <t>Jurkat</t> cells expressing the mouse FcγRIV with a luciferase reporter gene under transcriptional control of the nuclear factor-activated T (NFAT) cell promoter were then added and incubated for 6 h. Later luciferase activity was measured. The geometric mean AUC of fold induction of each group (pooled sera) was measured in technical duplicate.
Genetically Modified Jurkat Cells Expressing The Mouse Fcγriv With A Luciferase Reporter Gene, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/genetically modified jurkat cells expressing the mouse fcγriv with a luciferase reporter gene/product/Promega
Average 90 stars, based on 1 article reviews
genetically modified jurkat cells expressing the mouse fcγriv with a luciferase reporter gene - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

Image Search Results


Whole inactivated virus (WIV) with beta-propiolactone (BPL) and inactivated split vaccine combining BPL inactivation and Triton X-100 splitting were compared for two different vaccinations with WT viruses or mHA viruses. Vaccines were tested without adjuvant or with the addition of CpG 1018 (30 µg) as explained in Fig. . A Heatmap of IgG binding serum antibodies against a panel of recombinant influenza B HA proteins. B Heatmap of hemagglutination inhibition (HI) titer against a panel of influenza B viruses. C Heatmap of ADCC activity against three influenza B viruses. To perform the ADCC reporter assay, MDCK cells were infected with each virus at an MOI of 5 (single-cycle replication). One day after infection, mouse sera were added to the cells and incubated for 30 min and genetically modified Jurkat cells expressing the mouse FcγRIV with a luciferase reporter gene under transcriptional control of the nuclear factor-activated T (NFAT) cell promoter were then added and incubated for 6 h. Later luciferase activity was measured. The geometric mean AUC of fold induction of each group (pooled sera) was measured in technical duplicate.

Journal: NPJ Vaccines

Article Title: Preclinical evaluation of a universal inactivated influenza B vaccine based on the mosaic hemagglutinin-approach

doi: 10.1038/s41541-024-01014-8

Figure Lengend Snippet: Whole inactivated virus (WIV) with beta-propiolactone (BPL) and inactivated split vaccine combining BPL inactivation and Triton X-100 splitting were compared for two different vaccinations with WT viruses or mHA viruses. Vaccines were tested without adjuvant or with the addition of CpG 1018 (30 µg) as explained in Fig. . A Heatmap of IgG binding serum antibodies against a panel of recombinant influenza B HA proteins. B Heatmap of hemagglutination inhibition (HI) titer against a panel of influenza B viruses. C Heatmap of ADCC activity against three influenza B viruses. To perform the ADCC reporter assay, MDCK cells were infected with each virus at an MOI of 5 (single-cycle replication). One day after infection, mouse sera were added to the cells and incubated for 30 min and genetically modified Jurkat cells expressing the mouse FcγRIV with a luciferase reporter gene under transcriptional control of the nuclear factor-activated T (NFAT) cell promoter were then added and incubated for 6 h. Later luciferase activity was measured. The geometric mean AUC of fold induction of each group (pooled sera) was measured in technical duplicate.

Article Snippet: Genetically modified Jurkat cells expressing the mouse FcγRIV with a luciferase reporter gene under transcriptional control of the nuclear factor-activated T (NFAT) cell promoter were then added to the plate at 7.5× 10 4 cells in 25 μL/well (Promega) and incubated for 6 hours at 37 °C.

Techniques: Virus, Vaccines, Adjuvant, Binding Assay, Recombinant, HI Assay, Activity Assay, Reporter Assay, Infection, Incubation, Genetically Modified, Expressing, Luciferase, Control